Feb 27, 2023 10:52AM
Nov 8, 2022 06:40AM
Oct 13, 2022 05:24PM
Aug 9, 2022 06:49AM
Aug 9, 2022 06:45AM
Aug 8, 2022 06:45AM
May 26, 2022 06:46AM Reata Pharma (RETA) Announces FDA Filing Acceptance and Priority Review Designation for the NDA for Omaveloxolone
May 26, 2022 06:45AM
May 10, 2022 11:30AM
Dec 9, 2021 05:52AM
Dec 9, 2021 05:50AM
Dec 8, 2021 05:50PM
Dec 8, 2021 07:38AM
Dec 8, 2021 07:38AM Reata Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Discuss Bardoxolone for the Treatment of Patients With Chronic Kidney Disease Caused by Alport Syndrome
Nov 8, 2021 06:40AM
Oct 28, 2021 04:01PM
Aug 9, 2021 04:01PM
May 24, 2021 04:24AM
May 6, 2021 06:45AM
Apr 26, 2021 04:55PM
Apr 26, 2021 04:54PM Reata Announces FDA Accepted for Filing the NDA for Bardoxolone for the Treatment of Patients With Chronic Kidney Disease Caused by Alport Syndrome
Aug 10, 2020 06:45AM

15,423 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All